Relevance of oxidative stress for small intestinal injuries induced by nonsteroidal anti-inflammatory drugs: A

Yuki Baba1, Seiji Kawano2, Akinobu Takaki2

  • 1Department of Internal Medicine, Japanese Red Cross Himeji Hospital, Himeji, Japan.

Medicine
|December 17, 2024
PubMed

Insights

Nonsteroidal anti-inflammatory drug (NSAID) use can cause small intestinal injuries. This study found that NSAID-induced intestinal damage is linked to an imbalance in oxidative stress, particularly in nonaspirin users.

Area of Science:

  • Gastroenterology
  • Biochemistry
  • Clinical Medicine

Background:

  • Oxidative stress is implicated in NSAID-induced small intestinal mucosal injuries in mouse models.
  • Understanding this link in human NSAID users is crucial for clinical management.

Purpose of the Study:

  • To prospectively investigate the role of oxidative stress balance in NSAID users with small intestinal mucosal injury.
  • To differentiate the impact of aspirin versus nonaspirin NSAIDs on oxidative stress markers.

Main Methods:

  • A prospective study included 60 patients on continuous NSAID use for over 3 months with obscure gastrointestinal bleeding.
  • Small intestinal mucosal injuries were assessed using capsule endoscopy (CE).
  • Oxidative stress was evaluated by measuring reactive oxygen metabolites (d-ROMs) and oxidant capacity (OXY) levels.

Main Results:

  • 53% of patients showed small intestinal mucosal injuries on CE, with 24% having ulcers.
  • Lower serum OXY levels and higher d-ROM levels were associated with mucosal injury and ulcers, respectively.
  • Nonaspirin NSAID users exhibited significantly lower OXY levels and higher d-ROM levels in relation to mucosal injury and ulcers, unlike aspirin users.

Conclusions:

  • Nonaspirin NSAID-induced intestinal mucosal injury is associated with an imbalance in the antioxidant system, leading to increased oxidative stress.
  • Oxidative stress markers, d-ROMs and OXY, are relevant indicators in NSAID-associated small intestinal injuries.
  • Findings suggest a differential impact of aspirin versus nonaspirin NSAIDs on oxidative stress and intestinal health.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
347
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
242
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
135
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
133
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
244